Clinical Trial Update: Treatment of Mitochondrial Dysfunction in Rett Syndrome With Triheptanoin [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating triheptanoin for Rett syndrome is ongoing, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rett Syndrome

Drugs mentioned

• Triheptanoin (triheptanoin)

Snippet

Sponsor: Center for Rare Neurological Diseases, Norcross, GA | Conditions: Rett Syndrome | Phase 2 | Status: UNKNOWN